HeartLogic Clinical Data
“I think HeartLogic is very compelling because for the first time we have an algorithm that’s really been validated and is an algorithm that touches upon the things as clinicians that we think are important.”
Carl Fier, MD, FACC
Stay Up to Date
MultiSENSE was an international, multicenter, non-randomized feasibility study designed to determine how ambulatory sensor measurements change with worsening heart failure. The goal of the study was to develop and validate a multi-sensor algorithm for the early detection of worsening heart failure. The study concluded that the HeartLogic multi-sensor index and alert algorithm provide a sensitive and timely predictor of impending heart failure decompensation.1
Featured Clinical Data
Results From the MultiSENSE Study:
HeartLogic Index Trends2
HFSA 2019 - HeartLogic Heart Failure Diagnostic - Validated Evidence, Clinical Implementation and Utility
Watch selected excerpts from Boston Scientific’s Contemporary Forum at HFSA 2019.
Heart Rhythm 2019: HeartLogic™ A Multi-Sensor HF Diagnostic
Industry-leading experts discuss clinical evidence and practical consideration for HeartLogic™ Heart Failure Diagnostic at Heart Rhythm 2019.
Share Your HeartLogic Insights
We'd love to hear your insights on HeartLogic, including best practices, workflow tips, heart failure case studies and testimonials.
Increase Efficiencies. Improve Lives.
See how HeartLogic may help you increase clinic efficiencies, reduce hospital readmissions and improve patient outcomes.